CAPILLARY Capillary Technologies India Q2 FY27 results (Jul–Sep 2026) and concall
Capillary Technologies delivered strong operational and financial performance in Q2 FY27, with revenue growing 51% YoY to ₹271 crores and ARR expanding 51% YoY to ₹1,085 crores. Profitability scaled substantially as Adjusted EBITDA reached ₹44.8 crores (17% margin) and Q2 PAT rose to ₹22 crores, supported by operational leverage and break-even performance at recently acquired Session M. Operating cash flows remained strong at ₹113 crores for H1 FY27 (128% of Adjusted EBITDA), backed by zero long-term debt and ₹573 crores in cash balances.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY27: revenue up 72.3%, net profit up 1066.7% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 42 | 49 | 42 | 47 | 37 −12% | 31 −37% | 52 +24% | 81 +72% |
| EBITDA | 9 | 15 | 6 | 8 | 10 +11% | 16 +7% | 15 +150% | 37 +363% |
| Net profit | 0 | 7 | -5 | -3 | 1 | 10 +43% | 8 +260% | 29 +1067% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
